Israel-based Nevia Bio has raised $3.1M in seed funding to accelerate its mission to revolutionize the early detection of diseases affecting women. The startup, which has rebranded from its former name Gina Life, specializes in developing machine learning algorithms capable of identifying early indicators of women’s health issues, such as ovarian cancer. The latest funding round saw participation from MindUP Digital Health…
Delphinus Medical Technologies, a pioneer in dense breast medical imaging, has secured $12M in growth capital from Trinity Capital. The funding will accelerate the adoption of their SoftVue 3D Whole Breast Tomography System, which enhances early breast cancer detection. The SoftVue system gained FDA approval in 2021 as an adjunct to digital mammography for screening asymptomatic women with dense breast tissue. Addressing…
In a stride towards the development of innovative treatments for cancer, the U.S. Food and Drug Administration (FDA) has granted approval for the Phase I/II clinical trials of LBL-033, an anti-MUC16/CD3 bispecific antibody developed by Leads Biolabs. The biotech company is set to investigate the safety, efficacy, and pharmacokinetics of LBL-033 in combating advanced solid tumors, including ovarian cancer. This bispecific antibody,…
Mithra Pharmaceuticals and BCI Pharma, have announced promising preliminary data from their CSF-1R inhibitor program. The research indicates that Mithra’s lead CSF-1R inhibitor compound displays significant anti-tumor activity, and may work synergistically with PD-1 cancer immune checkpoint inhibitors. The CSF-1R inhibitor demonstrated its efficacy in three preclinical cancer models, modulating the tumor microenvironment and potentially reducing tumor growth by up to 59%.…
Pharma company Roche has been awarded World Health Organization (WHO) prequalification for its cobas HPV test. This move increases access to critical cervical cancer screening tools in low and lower-middle income countries, where the disease is most prevalent and deadly. Each year, over 600,000 women around the world are diagnosed with cervical cancer, with more than 340,000 succumbing to the preventable disease,…
Novartis has unveiled significant findings from the Phase III NATALEE trial, demonstrating that Kisqali (ribociclib) can effectively reduce the risk of cancer recurrence by 25.2% in patients with early breast cancer. The trial results were presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting and showcased a consistent and clinically meaningful benefit of Kisqali across a broad range of…
Perci Health, an online platform that helps people access multidisciplinary, supportive care throughout their cancer journey, has raised £3.4m in seed funding led by Octopus Ventures. The new funds will allow the company to further invest into its technology roadmap, continue to expand the team and grow access for cancer patients through new partnerships with large employers and insurers. In the last few…
During its annual health event, The Check Up, Google unveiled several new healthcare partnerships with a focus on artificial intelligence. In recent years, the tech giant has invested significant attention and resources into healthcare in a bid to further integrate itself into the burgeoning industry. One highlight of the event was Google’s announcement that its Med-PaLM 2 language model can now provide…
